Enbucrilate
- Generic Name
- Enbucrilate
- Drug Type
- Small Molecule
- Chemical Formula
- C8H11NO2
- CAS Number
- 6606-65-1
- Unique Ingredient Identifier
- F8CEP82QNP
- Background
Enbucrilate is under investigation in clinical trial NCT02468206 (Secondary Prophylaxis of Gastric Variceal Bleed).
Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection
Phase 3
- Conditions
- Bleeding Esophageal Varices
- Interventions
- Drug: Injection Sclerotherapy
- First Posted Date
- 2018-01-02
- Last Posted Date
- 2018-04-24
- Lead Sponsor
- Sherief Abd-Elsalam
- Target Recruit Count
- 113
- Registration Number
- NCT03388125
- Locations
- 🇪🇬
Sherief Abd-Elsalam, Tanta, Egypt
Primary Prophylaxis of Gastric Variceal Bleed
Not Applicable
- Conditions
- Gastric Varices
- Interventions
- Procedure: Balloon-occluded retrograde transvenous obliterationProcedure: Endoscopic cyanoacrylate injection
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT02468180
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO
Not Applicable
- Conditions
- Gastric Varices
- Interventions
- Procedure: Balloon-occluded retrograde transvenous obliterationProcedure: Endoscopic cyanoacrylate injection
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT02468167
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Secondary Prophylaxis of Gastric Variceal Bleed
Not Applicable
Completed
- Conditions
- Gastric Varices
- Interventions
- Procedure: Balloon-occluded retrograde transvenous obliterationProcedure: Endoscopic cyanoacrylate injection
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 64
- Registration Number
- NCT02468206
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath